...
首页> 外文期刊>Canadian journal of anesthesia: Journal canadien d'anesthesie >Anesthetic management of a parturient with carnitine palmitoyltransferase II deficiency.
【24h】

Anesthetic management of a parturient with carnitine palmitoyltransferase II deficiency.

机译:肉毒碱棕榈酰转移酶II缺乏症的产妇的麻醉处理。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To report the anesthetic management of a patient with carnitine palmitoyltransferase II deficiency who presented for labour and delivery. CLINICAL FEATURES: A 30-yr-old primiparous woman with known carnitine palmitoyltransferase II deficiency and a past history of exercise induced muscle pain, weakness and myoglobinuria presented in active labour. Management consisted of an early epidural for labour and continuous dextrose infusion with frequent blood sugar monitoring. She had an uneventful spontaneous vaginal delivery. She experienced a single asymptomatic episode of hypoglycemia on the first postpartum day. Her serum creatine kinase was six times normal at 24 hr post-delivery and remained elevated for three days without evidence of rhabdomyolysis. The remainder of her postpartum course was uneventful. CONCLUSION: Labour and delivery is a potential precipitant of rhabdomyolysis in patients with carnitine palmitoyltransferase II deficiency. The normal postpartum creatine kinase elevation (two to four times baseline at 24 hr) must be taken into account when monitoring these patients. On the basis of the physiologic principles, institution of early epidural analgesia to blunt the stress response to labour and delivery, continuous dextrose infusion and frequent glucose monitoring during labour and postpartum are the mainstays of management.
机译:目的:报告患有肉碱棕榈酰转移酶II缺乏症并准备分娩和分娩的患者的麻醉管理。临床特征:一名已知肉碱棕榈酰转移酶II缺乏症且有运动史的30岁初产妇女在活动中表现出肌肉疼痛,无力和肌红蛋白尿。管理包括早期硬膜外分娩和连续葡萄糖输注,并经常监测血糖。她自然流产。产后第一天,她经历了一次无症状的低血糖发作。在分娩后24小时,她的血清肌酸激酶是正常水平的六倍,并且在没有横纹肌溶解迹象的情况下保持了三天的升高。她产后课程的其余部分都很顺利。结论:分娩和分娩是肉毒碱棕榈酰转移酶II缺乏症患者横纹肌溶解的潜在诱因。监测这些患者时,必须考虑正常的产后肌酸激酶升高(24小时基线水平的2至4倍)。根据生理原理,采用硬膜外早期镇痛以减轻对分娩和分娩的压力反应,持续输注葡萄糖以及分娩和产后频繁监测血糖是管理的主要手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号